Navin Varadarajan, Ph.D.
Affiliations: | 2007 | Chemistry | University of Texas at Austin, Austin, Texas, U.S.A. |
Area:
Antibody and Enzyme EngineeringGoogle:
"Navin Varadarajan"Mean distance: 8.61
Parents
Sign in to add mentorBrent L. Iverson | grad student | 2007 | UT Austin | |
(Engineering highly active and specific protease variants.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Rezvan A, Romain G, Fathi M, et al. (2024) Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling. Nature Cancer |
Montalvo MJ, Bandey IN, Rezvan A, et al. (2024) Decoding the mechanisms of chimeric antigen receptor (CAR) T cell-mediated killing of tumors: insights from granzyme and Fas inhibition. Cell Death & Disease. 15: 109 |
Romain G, Strati P, Rezvan A, et al. (2022) Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses. The Journal of Clinical Investigation |
Bandey IN, Adolacion JRT, Romain G, et al. (2021) Designed improvement to T-cell immunotherapy by multidimensional single cell profiling. Journal For Immunotherapy of Cancer. 9 |
Rath JA, Bajwa G, Carreres B, et al. (2020) Single-cell transcriptomics identifies multiple pathways underlying antitumor function of TCR- and CD8αβ-engineered human CD4 T cells. Science Advances. 6: eaaz7809 |
Daher M, Basar R, Gokdemir E, et al. (2020) Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells. Blood |
Doshi A, Sadeghi F, Varadarajan N, et al. (2020) Small-molecule inducible transcriptional control in mammalian cells. Critical Reviews in Biotechnology. 1-20 |
Fousek K, Watanabe J, Joseph SK, et al. (2020) CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression. Leukemia |
Ramesh B, Abnouf S, Mali S, et al. (2019) Engineered ChymotrypsiN for Mass Spectrometry-Based Detection of Protein Glycosylation. Acs Chemical Biology |
Liadi I, Singh H, Romain G, et al. (2019) Defining potency of CAR T cells: Fast and furious or slow and steady. Oncoimmunology. 8: e1051298 |